Physician profile
James Yoon
NPI 1750451977
$7,829.05
in general payments reported to CMS, 2019-2025
20 companies · $663 in 2025
The $663 reported for 2025 was more than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,140 · 2020: $1,692 · 2021: $1,890 · 2022: $1,360 · 2023: $872 · 2024: $212 · 2025: $663.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,747.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,747.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $3,125.56 | 2019-2023 | Symtuza |
| Viiv Healthcare Company | $1,473.48 | 2020-2025 | Cabenuva, Apretude, Dovato |
| Gilead Sciences, INC. | $1,089.96 | 2019-2025 | Yeztugo |
| Theratechnologies INC. | $468.13 | 2019-2025 | Trogarzo, Egrifta, Egrifta Sv |
| Insmed, INC. | $396.57 | 2019-2021 | |
| Shionogi INC | $326.36 | 2019-2023 | Fetroja |
| Melinta Therapeutics, LLC | $222.21 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $145.53 | 2021-2023 | Pifeltro, Delstrigo |
| Cumberland Pharmaceuticals, INC. | $97.33 | 2019-2023 | Vibativ |
| Paratek Pharmaceuticals, INC. | $89.20 | 2021-2025 | Nuzyra |
| Abbvie INC. | $73.84 | 2022-2023 | Dalvance |
| Janssen Scientific Affairs, LLC | $69.39 | 2022-2023 | |
| Daiichi Sankyo INC. | $47.51 | 2020 | |
| Amgen INC. | $46.19 | 2019-2020 | |
| Astellas Pharma US INC | $41.70 | 2019-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $28.43 | 2021 | |
| Pfizer INC. | $24.88 | 2021 | |
| Ucb, INC. | $24.06 | 2022 | |
| Medtronic, INC. | $20.71 | 2024 | Signia |
| Philips North America LLC | $18.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Yoon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.